健康头发的科学：脱发原因与生发方法

健康头发的科学、脱发原因及头发再生方法

摘要

本集涵盖头发生长的完整生物学原理——从干细胞和毛囊解剖结构，到调节生长周期的激素与机械因素。Andrew Huberman 解释了为何脱发随年龄增长而发生，特别是dihydrotestosterone（DHT，双氢睾酮）的作用机制，并概述了一系列基于证据的干预措施——包括机械性和化学性手段——以减缓、阻止或逆转男女性脱发。

---

核心要点

• 每根头发在毛球内都有其专属的干细胞龛；保护和重新激活这些干细胞是大多数脱发治疗的核心目标。
• 脱发主要由**DHT（双氢睾酮）**驱动，DHT抑制促生长信号IGF-1和环磷酸腺苷（cyclic AMP），从而缩短生长期（anagen期）。
• 到50岁时，约50%的男性和女性会出现明显脱发，脱发通常从30岁左右开始逐渐显现。
• **Minoxidil（米诺地尔）**主要通过增加毛囊干细胞龛的血流量来发挥作用，从而延长生长期——但必须无限期使用以维持效果。
• Microneedling（微针治疗）（针深1–2.5mm）可重新激活处于半静止状态的干细胞，与米诺地尔联合使用时，即使在此前已经秃顶的”死区”也显示出有效性。
• 米诺地尔 + 微针治疗的组合疗效明显优于单独使用任一治疗方法。
• 头皮张力会减少毛囊的血流供应；肉毒素注射和头皮按摩等疗法旨在缓解这种张力并改善血液循环。
• DHT本身并无害——它支持精神活力、性欲、力量和驱动力——因此针对脱发管理DHT需要谨慎、有针对性的方法。
• 脱发模式（前额、头顶或弥漫性）由头皮上雄激素受体的分布决定，该分布由遗传决定。
• 关于可以通过外祖父预测秃顶的说法是错误的——雄激素受体的遗传模式来自母系，但参考外祖母会更具参考价值（即便如此也并不精确）。

---

详细笔记

毛囊解剖结构

• 每根头发由三个部分组成：
  • 毛干 — 皮肤表面以上的可见部分
  • 毛根 — 向下穿过表皮延伸至真皮层
  • 毛球 — 洞穴状的底部结构，含有干细胞和黑色素细胞
• 毛球包含：
  • 干细胞（祖细胞，通过有丝分裂产生子细胞，子细胞形成角蛋白）
  • 黑色素细胞（产生melanin，即给头发着色的色素）
  • 毛细血管，为头发主动生长提供氧气和营养——这对活跃的头发生长至关重要
• 相邻结构：
  • 皮脂腺 — 分泌皮脂，起到皮肤防水及抗菌/抗微生物保护作用
  • 竖毛肌 — 在寒冷或恐惧时收缩，引起鸡皮疙瘩，并将温暖空气留在毛发之间

头发生长的三个阶段

阶段	描述	持续时间（头皮）
生长期（Anagen）	主动生长；干细胞产生角蛋白	2–8年
退行期（Catagen）	毛发从毛球向上退缩；生长停止	不定
休止期（Telogen）	静止期；干细胞进入静止状态；头发可能脱落也可能不脱落	不定

• 眉毛的生长期仅数月（生长速度约4.2mm/月），这也解释了为何眉毛不会无限生长。
• 不同人之间头发”长度”的差异，更可能是由于生长期持续时间的差异，而非生长速率不同。
• 休止期结束后，若干细胞仍然存活、氧气和血流供应充足，且激素条件有利，毛囊可以重新进入生长期。

头发生长的激素调节

促进因素（延长生长期）：

• IGF-1（胰岛素样生长因子1）— 由肝脏产生；延长生长期
• 环磷酸腺苷（Cyclic AMP） — 第二信使，支持干细胞活性和毛囊生长

抑制因素（缩短生长期或延长退行期/休止期）：

• 磷酸二酯酶（PDE） — 限制环磷酸腺苷活性的酶
• TGF-beta-2 — 抑制生长；促进生长期结束后的过渡

DHT与雄激素相关性脱发：

• 睾酮通过5-α还原酶转化为DHT
• DHT与雄激素受体的结合亲和力是睾酮的5倍——使其成为最强效的雄激素
• DHT抑制IGF-1和环磷酸腺苷，缩短生长期并促进退行期/休止期
• 随着年龄增长，5-α还原酶活性增加，将更多睾酮转化为DHT，这解释了为何脱发在30–50岁左右加速
• 头皮各区域DHT受体密度不同，决定了脱发的模式（前额、头顶或弥漫性）
• 女性也产生睾酮和DHT；雄激素相关性脱发影响男女两性

---

治疗方法

血流/机械性方法

Minoxidil（米诺地尔/落健）

• 最初作为降压药开发；具有促血管扩张作用
• 作用机制：增加毛囊干细胞龛的血流量 → 延长生长期
• 给药途径：口服或外用（5%溶液）
• 口服剂量范围：0.25mg至5mg/天（从低剂量开始逐渐增加）
• 外用：5%溶液，每天一次，涂抹于头皮后留置3–5分钟
• 副作用：体液潴留/水肿、头晕、头痛、泌乳素升高（可降低性欲和幸福感）、大剂量时可能出现男性乳房发育
• 重要提示：米诺地尔很可能是终身用药——停止治疗通常会导致已恢复的效果消失
• 外用米诺地尔仍可通过毛囊毛细血管进入体循环

低剂量Tadalafil（他达拉非/希爱力）

• 最初是前列腺健康药物；可广泛增加血流量
• 用于头发/头皮血流的剂量：2.5–5mg
• 作用机制与米诺地尔类似（扩张血管至干细胞龛）
• 副作用少于米诺地尔；部分医生已将其用于头发养护处方

Microneedling（微针治疗）

• 使用带针滚轮（针长0.5mm–2.5mm）在头皮上滚动
• 作用机制：微创伤触发休止期半静止干细胞的重新激活；刺激局部Inflammation 炎症（炎症）级联反应 → 产生增殖信号
• 针长1–2.5mm的效果优于较短的针
• 可能引起轻微出血和暂时性头皮炎症——这是治疗机制的一部分
• 与米诺地尔联合使用的效果远优于单独使用任一治疗
• 是唯一被证明可以恢复**“死区”（完全秃顶区域）的方法——但仅在与米诺地尔联合使用时有效；恢复可能需要30–50周**
• 支持依据：“Microneedling and its Use in Hair Loss Disorders: A Systematic Review”（链接见节目说明）

头皮按摩

• 可短暂增加血流量；单独使用可能效果不足，但作为辅助手段具有支持作用

肉毒素（肉毒杆菌神经毒素）

• 注射至头皮以缓解头皮皮肤的张力/收缩
• 作用机制：减少皮肤张力 → 改善毛囊龛的血流量
• 证据来源于回状头皮（cutis verticis gyrata）（伴有模式性脱发的脊状头皮）：肉毒素缓解了皮肤折叠并改善了头发生长
• 必须由熟练的医疗人员操作；效果会消退，需重复治疗
• 大规模临床数据有限；被认为是合理但侵入性较高的选择

PRP（富血小板血浆）

• 抽取血液，离心分离，提取血小板后重新注射至头皮
• 作用机制：富含营养

---

English Original 英文原文

The Science of Healthy Hair, Hair Loss, and How to Regrow Hair

Summary

This episode covers the complete biology of hair growth — from stem cells and hair follicle anatomy to the hormonal and mechanical factors that regulate growth cycles. Andrew Huberman explains why hair loss occurs with age, particularly through the action of dihydrotestosterone (DHT), and outlines a range of evidence-based interventions — both mechanical and chemical — to slow, halt, or reverse hair loss in men and women.

---

Key Takeaways

• Every hair has its own stem cell niche within the hair bulb; protecting and reactivating these stem cells is the central goal of most hair loss treatments.
• Hair loss is driven largely by DHT (dihydrotestosterone), which inhibits the growth-promoting signals IGF-1 and cyclic AMP, shortening the anagen (growth) phase.
• By age 50, approximately 50% of men and women experience noticeable hair loss, with loss beginning gradually around age 30.
• Minoxidil works primarily by increasing blood flow to the hair follicle stem cell niche, extending the anagen phase — but must be used indefinitely to maintain results.
• Microneedling (1–2.5mm needle depth) can reactivate semi-quiescent stem cells and, when combined with minoxidil, has shown effectiveness even in previously bald “dead zones.”
• The combination of minoxidil + microneedling is significantly more effective than either treatment alone.
• Scalp tension reduces blood flow to follicles; treatments like Botox injections and scalp massage aim to relieve this tension and improve circulation.
• DHT is not inherently harmful — it supports mental vigor, libido, strength, and drive — so managing DHT for hair loss requires careful, targeted approaches.
• The pattern of hair loss (front vs. crown vs. diffuse) is determined by the distribution of androgen receptors on the scalp, which is genetically inherited.
• The myth that you can predict balding from your mother’s father is false — the pattern of androgen receptors comes from the maternal line, but looking at your maternal grandmother would be more informative (and even that is imprecise).

---

Detailed Notes

Hair Follicle Anatomy

• Each hair has three components:
  • Shaft — the visible portion above the skin
  • Root — extends down through the epidermis into the dermis
  • Hair bulb — the cave-like base containing stem cells and melanocytes
• The hair bulb contains:
  • Stem cells (progenitor cells that divide via mitosis to produce daughter cells forming keratin)
  • Melanocytes (produce melanin, the pigment that colors hair)
  • Capillaries supplying oxygen and nutrients — essential for active hair growth
• Adjacent structures:
  • Sebaceous gland — produces sebum, which waterproofs skin and provides antibacterial/antimicrobial protection
  • Arrector pili muscle — contracts in response to cold or fear, causing goosebumps and trapping warm air between hairs

The Three Phases of Hair Growth

Phase	Description	Duration (Scalp)
Anagen	Active growth; stem cells produce keratin proteins	2–8 years
Catagen	Hair recedes from the bulb upward; growth stops	Varies
Telogen	Resting phase; stem cells become quiescent; hair may or may not return	Varies

• Eyebrow anagen phase: only a few months (growing ~4.2mm/month), explaining why eyebrows don’t grow indefinitely.
• Hair “length” differences between people are more likely due to differences in anagen phase duration, not growth rate.
• After telogen, a follicle can re-enter anagen if stem cells remain viable, oxygen and blood flow are adequate, and hormonal conditions are favorable.

Hormonal Regulation of Hair Growth

Accelerators (extend anagen phase):

• IGF-1 (Insulin-like Growth Factor 1) — produced by the liver; extends the growth phase
• Cyclic AMP — a second messenger that supports stem cell activity and follicle growth

Brakes (shorten anagen or extend catagen/telogen):

• PDE (phosphodiesterase) — enzyme that limits cyclic AMP activity
• TGF-beta-2 — inhibits growth; promotes transition out of anagen

DHT and Androgen-Related Hair Loss:

• Testosterone is converted to DHT by the enzyme 5-alpha reductase
• DHT binds the androgen receptor at 5× the affinity of testosterone — making it the most potent androgen
• DHT inhibits IGF-1 and cyclic AMP, shortening the anagen phase and promoting catagen/telogen
• As people age, more 5-alpha reductase activity converts more testosterone to DHT, explaining why hair loss accelerates from around age 30–50
• DHT receptor density varies by scalp region, determining the pattern of hair loss (frontal, crown, diffuse)
• Women also produce testosterone and DHT; androgen-related alopecia affects both sexes

---

Treatment Approaches

Blood Flow / Mechanical Approaches

Minoxidil (Rogaine)

• Originally developed as an antihypertensive drug; promotes vasodilation
• Mechanism: increases blood flow to the hair follicle stem cell niche → extends anagen phase
• Routes: oral or topical (5% solution)
• Oral dosage range: 0.25 mg to 5 mg/day (start low and titrate up)
• Topical: 5% solution, applied once daily, leave on scalp 3–5 minutes
• Side effects: fluid retention/edema, dizziness, headache, elevated prolactin (which can reduce libido and well-being), gynecomastia at high doses
• Important: minoxidil is likely a lifelong commitment — stopping treatment typically results in loss of gains
• Topical minoxidil can still enter systemic circulation via follicle capillaries

Low-Dose Tadalafil (Cialis)

• Originally a prostate health drug; increases blood flow broadly
• Dosage for hair/scalp blood flow: 2.5–5 mg
• Mechanistically similar to minoxidil (vasodilation to stem cell niche)
• Fewer side effects than minoxidil; being prescribed by some doctors for hair maintenance

Microneedling

• Uses a roller with needles (0.5mm–2.5mm length) rolled across the scalp
• Mechanism: micro-injury triggers reactivation of semi-quiescent stem cells in telogen phase; stimulates local Inflammation 炎症 cascade → proliferation signals
• Needle lengths of 1–2.5mm appear more effective than shorter needles
• May cause minor bleeding and temporary scalp inflammation — this is part of the mechanism
• Combination with minoxidil is substantially more effective than either treatment alone
• The only approach shown to recover “dead zones” (completely bald regions) — but only when combined with minoxidil; recovery may take 30–50 weeks
• Supported by: “Microneedling and its Use in Hair Loss Disorders: A Systematic Review” (link provided in show notes)

Scalp Massage

• Transiently increases blood flow; unlikely to be sufficient alone but supportive as an adjunct

Botox (Botulinum Neurotoxin)

• Injected into the scalp to relieve tension/contraction of scalp skin
• Mechanism: reduces skin tension → improves blood flow to follicle niche
• Evidence from cutis verticis gyrata (ridged scalp skin with pattern hair loss): Botox relieved folds and improved hair growth
• Must be done by a skilled practitioner; wears off and requires repeat treatments
• Limited large-scale clinical data; considered a reasonable but more invasive option

PRP (Platelet-Rich Plasma)

• Blood is drawn, spun down, platelets extracted and re-injected into scalp
• Mechanism: enriched nutrient